For regulated normal cells, these findings suggest a key role of ADAR2 editing activity in controlling the growth of gliomas [5, 22, 26, 32] because this enzyme seems to prevent cell proliferation by the Akt pathway [16, 34] and/or modulates the cell cycle [10]. Here, AKT1 is linked to central nervous system cancer.